Abatacept Versus Adalimumab Head-to-Head

Completed · Phase 3

Conditions studied: Rheumatoid Arthritis

In brief

The purpose of this study is demonstrate that subcutaneous abatacept is non-inferior (no worse than) to subcutaneous adalimumab in the treatment of subjects with rheumatoid arthritis who are biologic naive

Key facts

Study ID
NCT00929864
Run by
Bristol-Myers Squibb
People needed
869
Starts
2009-10-01
Expected to finish
2012-11-01
Last updated by the study team
2014-02-04

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.